Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XOM vs GSK✓SelectedUSD · GSKXOM vs GSK performance historyLatest closeAs of-1.03%11/19
Stock and ETF performance explorer

XOM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+39.0%
GSK return
+5.3%
Excess return
+33.7%
Maximum drawdown
-20.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.0%-1.6%+0.5%-1.2%
7D-5.8%-4.7%-1.1%-6.3%
30D-10.1%-4.7%-5.4%-10.4%
3M-2.9%-8.8%+5.8%-3.7%
6M-1.0%-4.6%+3.7%-1.2%
YTD+35.6%+1.0%+34.6%+35.1%
1Y+39.0%+6.9%+32.1%+38.8%
All+39.0%+5.3%+33.7%+38.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling